50.22
0.00
(0.00%)
As of 8:19:45 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,017,900.00
1,017,900.00
1,136,300.00
1,511,400.00
1,223,500.00
Investing Cash Flow
-681,100.00
-681,100.00
-855,900.00
-1,021,000.00
-525,000.00
Financing Cash Flow
413,600.00
413,600.00
-311,300.00
-910,300.00
-48,600.00
End Cash Position
1,220,900.00
1,220,900.00
483,200.00
515,000.00
910,500.00
Capital Expenditure
-550,100.00
-550,100.00
-660,200.00
-506,400.00
-355,500.00
Issuance of Capital Stock
8,000.00
8,000.00
14,600.00
35,800.00
564,800.00
Issuance of Debt
638,500.00
638,500.00
633,900.00
826,300.00
946,200.00
Repayment of Debt
-90,000.00
-90,000.00
-82,900.00
-1,280,000.00
-1,304,500.00
Repurchase of Capital Stock
-55,800.00
-55,800.00
-15,800.00
-3,600.00
--
Free Cash Flow
467,800.00
467,800.00
476,100.00
1,005,000.00
868,000.00
12/31/2020 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EZB.BE Enzo Biochem Inc
0.6300
-2.33%
NN6.F NanoRepro AG
1.4200
-4.05%
IDHCl.XC
MVF.AX Monash IVF Group Limited
1.2150
+0.83%
VIMIAN.ST Vimian Group AB (publ)
38.40
+2.81%
DAP.DE Danaher Corporation
237.95
+1.21%
PRM.L Proteome Sciences plc
3.6200
-14.82%
SZLS.TO StageZero Life Sciences Ltd.
0.0400
0.00%
DAP.F Danaher Corporation
237.40
+1.22%
AGL.L ANGLE plc
11.25
+1.12%